Outcomes In Phaco-Dmek Vs Dmek And Phaco In 2 Times With Premium Iol
Published 2023 - 41st Congress of the ESCRS
Reference: PP08.04 | Type: Free paper | DOI: 10.82333/j2k6-ye18
Authors: Antonio Cano-Ortiz* 1 , Álvaro Sánchez Ventosa 1 , Alberto Villarrubia 1 , Timoteo González Cruces 2 , Elisa Palacin 1 , Maria Dolores López-Perez 1 , Alberto Membrillo del Pozo 3 , Vanesa Diaz Mesa 2
1Cornea, refractive and external disease ,Arruzafa Hospital,Cordoba ,Spain, 2Arruzafa Hospital,Cordoba ,Spain, 3Cordoba University,Cordoba ,Spain
Purpose
To describe the functional results after implantation of Vivity (or Vivity toric) in patients requiring DMEK and cataract surgery in one or two procedure.
Setting
Arruzafa Ophthalmological Hospital, Cordoba, Spain.
Methods
Prospective, descriptive, double arm, 3 month follow up. 1 surgeon
The study comprised 30 eyes undergoing phacodmek surgery. Patients were separated into two groups: group 1 (15 patients; 15 eyes) received DMEK surgery and 3 month after phaco + vivity IOL and group 2 (15 patients; 15 eyes) received a phacodmek + vivty IOL procedure.
The inclusion criteria were cataract patients with Fuchs Dystrophy requiring endothelial transplant (DMEK) and phaco + IOL
Results
13 patients have completed the follow-up. 6 from group 1 and 7 from group 2. The UCDVA were 0.64±0.21 in group 1, and 0.60±0.17 in group 2. The CDVA were 0.94±0.19 and 0.82±0.14 respectively. No statistical differences in these parameters.
There were no differences in sphere, cylinder and spherical equivalent results
The postoperative endothelial cell count were 1332.16±203.82 in group 1, and 1928.85±408.43 with a p value of 0.007749.
Conclusions
The use of Vivity IOL in patients with Fuchs and DMEK seems to be a safe and effective option.
Phaco-DMEK is more respectful to the endothelium than DMEK and phaco in two separate procedures.
Performing phaco three months after DMEK doesn’t make us more predictable in sphere and astigmatism results.
Non-diffractive Premium platforms may be an option in patients with endothelial pathology and recovery after standardized DMEK